Folate Pathway Genetic Polymorphisms are Related to Attention Disorders in Childhood Leukemia Survivors
Received 7 November 2006; received in revised form 24 April 2007; accepted 29 May 2007. published online 10 October 2007.
Objective
To test the hypothesis that 5,10-methylenetetrahydroreductase (MTHFR) polymorphisms can partially explain the individual variation in developing attention-deficit/hyperactivity disorder (ADHD) after acute lymphoblastic leukemia (ALL) therapy.
Study design
Parents of 48 survivors of childhood ALL completed a clinical diagnostic process to identify subtypes of ADHD. Genotyping was performed with peripheral blood DNA for MTHFR (C677T and A1298C) polymorphisms.
Results
Eleven of the 48 patients (22.9%) had scores consistent with the inattentive symptoms of ADHD. Patients with genotypes related to lower folate levels (11 out of 39; 39.2%) were more likely to have ADHD. The A1298C genotype appeared to be the predominant linkage to the inattentive symptoms, leading to a 7.4-fold increase in diagnosis, compared with a 1.3-fold increase for the C677T genotype. Age at diagnosis and sex were not associated with inattentiveness.
Conclusions
Preliminary data imply a strong relationship between MTHFR polymorphisms and the inattentive symptoms of ADHD in survivors of childhood ALL.
dDivision of AIDS & Health and Behavior Research, National Institute of Mental Health, Rockville, MD
eChildhood Cancer Epidemiology and Prevention Center, Houston, TX.
Reprint requests: Kevin R. Krull, PhD, Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, 332 N. Lauderdale St, MS 735, Memphis, TN 38105-2794.
No author reports any conflict of interest associated with this study.